Unicorn Nest news
Tailor Brands raises $50M, aims to be one-stop shop for small businesses to launch
– Tailor Brands, a startup that automates parts of the branding and marketing process for small businesses, announced it has raised $50 million in Series C funding.
– GoDaddy led the round as a strategic partner and was joined by OurCrowd and existing investors Pitango Growth, Mangrove Capital Partners, Armat Group, Disruptive VC and Whip Media founder Richard Rosenblatt.
– The company, headquartered in New York and Tel Aviv, is now compiling the components for a one-stop SaaS platform — providing the design, branding and marketing services a small business owner needs to launch and scale operations, and within minutes.
– Over the past year, more users are flocking to Tailor Brands; the company is onboarding some 700,000 new users per month for help in the earliest stages of setting up their business.
Unicorn Nest news
Perception Point Raises $28 Million in Series B Funding to Advance Messaging and Collaboration Protection for Enterprise Users
– Perception Point, a leading email and collaboration security company, offering fast interception of content-based attacks as a service, announced it has raised $28 million in Series B, bringing the total funding to $48 million.
– The new funding round was led by Red Dot Capital Partners and joined by global investor NGP Capital along with existing investors Pitango Venture Capital and State of Mind Ventures (SOMV).
– Yoram Oron and Atad Peled from Red Dot Capital Partners, and Bo Ilsoe from NGP Capital will be joining the company’s board of directors.
– Funds from this round will be used to fuel rapid growth, expand to new markets, accelerate product innovation and grow the team to support customer demand.
Unicorn Nest news
Variantyx Secures $20M in Series C Funding
– Variantyx, a Boston, MA-based hereditary disease testing company, secured $20M in Series C funding.
– The round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango Venture Capital, New Era Capital Partners, 20/20 HealthCare Partners.
– In conjunction with the funding, Zafrira Avnur, PhD, Quark Venture Chief Scientific Officer & Partner, will join the Variantyx board of directors.
– The company intends to use the funds for development of its tumor diagnostic solutions and the expansion of sales.
